Home

Concord Drugs Ltd Quarterly Result

Image

Concord Drugs Ltd

NSE: CONCORDDRUGS

Net Profit - Last Quarter

₹ 0.23 Cr.

Last updated on: Jan 15, 2025

Key Highlights

  • The revenue of Concord Drugs Ltd for the Dec '24 is ₹ 10.8 crore as compare to the Sep '24 revenue of ₹ 12.37 crore. This represent the decline of -12.691995%.
  • The ebitda of Concord Drugs Ltd for the Dec '24 is ₹ 1.39 crore as compare to the Sep '24 ebitda of ₹ 0.88 crore. This represent the growth of 57.954544%.
  • The net profit of Concord Drugs Ltd for the Dec '24 is ₹ 0.23 crore as compare to the Sep '24 net profit of ₹ 0.04 crore. This represent the growth of 475%.

Results Analysis

Market Price of Concord Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Concord Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 202535.59
14 Jan 202537.72
13 Jan 202536.83
10 Jan 202536.71
09 Jan 202537.87
08 Jan 202537.93
07 Jan 202537.62
06 Jan 202537.38
03 Jan 202538.46
02 Jan 202538.31

Historical Revenue of Concord Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Concord Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Drugs Ltd

No data available

* All values are in crore

Concord Drugs Ltd News Hub

Concord Drugs consolidated net profit declines 93.88% in the June 2024 quarter

Net profit of Concord Drugs declined 93.88% to Rs 0.03 crore in the quarter ended June 2024 as again

Read more

10 Aug 2024

Concord Drugs to table results

Concord Drugs will hold a meeting of the Board of Directors of the Company on 9 August 2024. Powered

Read more

06 Aug 2024

Concord Drugs fixes board meeting date

Concord Drugs will hold a meeting of the Board of Directors of the Company on 6 September 2024. Powe

Read more

03 Sep 2024

Concord Drugs to conduct AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held on 30 Sept

Read more

19 Sep 2024

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Concord Drugs Ltd

What key financial metrics are included in Concord Drugs Ltd's quarterly results?

Key financial metrics in Concord Drugs Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Concord Drugs Ltd announce its quarterly results?

Concord Drugs Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Concord Drugs Ltd's quarterly performance impact its stock price?

Concord Drugs Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Concord Drugs Ltd's quarterly results on dividends?

The impact of Concord Drugs Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Concord Drugs Ltd's quarterly results?

Yes, Concord Drugs Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions